Kenvue Inc. Research and Development Expense
Kenvue Inc. (KVUE) reported Research and Development Expense of $94.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- Kenvue Inc. research and development expense for the quarter ending 2026-06-28 was $94.00M, a 3.30% increase year-over-year.
- Kenvue Inc. research and development expense for the quarter ending 2026-03-29 was $84.00M, a 15.15% decline year-over-year.
- Kenvue Inc. research and development expense for the quarter ending 2025-12-28 was $98.00M, a 7.55% decline year-over-year.
- Kenvue Inc. research and development expense for the quarter ending 2025-09-28 was $94.00M, a 3.09% decline year-over-year.
- Kenvue Inc. research and development expense for fiscal 2025 was $382.00M, a 6.37% decline from fiscal 2024.
- Kenvue Inc. research and development expense for fiscal 2024 was $408.00M, a 2.26% increase from fiscal 2023.
- Kenvue Inc. research and development expense for fiscal 2023 was $399.00M, a 6.40% increase from fiscal 2023.
- Kenvue Inc. research and development expense for fiscal 2023 was $375.00M, a 5.63% increase from fiscal 2022.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-28 | $94.00M 10-Q · filed 2026-08-06 | $178.00M 10-Q · filed 2026-08-06 | $276.00M derived: sum of 3 quarters · filed 2026-08-06 | $370.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-29 | $84.00M 10-Q · filed 2026-05-07 | $182.00M derived: sum of 2 quarters · filed 2026-05-07 | $276.00M derived: sum of 3 quarters · filed 2026-05-07 | $367.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-28 | $98.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $192.00M derived: sum of 2 quarters · filed 2026-02-20 | $283.00M derived: sum of 3 quarters · filed 2026-08-06 | $382.00M 10-K · filed 2026-02-20 |
| 2025-09-28 | $94.00M 10-Q · filed 2025-11-03 | $185.00M derived: sum of 2 quarters · filed 2026-08-06 | $284.00M 10-Q · filed 2025-11-03 | $390.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-29 | $91.00M 10-Q · filed 2026-08-06 | $190.00M 10-Q · filed 2026-08-06 | $296.00M derived: sum of 3 quarters · filed 2026-08-06 | $393.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-30 | $99.00M 10-Q · filed 2026-05-07 | $205.00M derived: sum of 2 quarters · filed 2026-05-07 | $302.00M derived: sum of 3 quarters · filed 2026-05-07 | $407.00M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-29 | $106.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $203.00M derived: sum of 2 quarters · filed 2026-02-20 | $308.00M derived: sum of 3 quarters · filed 2026-02-20 | $408.00M 10-K · filed 2026-02-20 |
| 2024-09-29 | $97.00M 10-Q · filed 2025-11-03 | $202.00M derived: sum of 2 quarters · filed 2025-11-03 | $302.00M 10-Q · filed 2025-11-03 | $435.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $105.00M 10-Q · filed 2025-08-07 | $205.00M 10-Q · filed 2025-08-07 | $338.00M derived: sum of 3 quarters · filed 2026-02-20 | $416.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $100.00M 10-Q · filed 2025-05-08 | $233.00M derived: sum of 2 quarters · filed 2026-02-20 | $311.00M derived: sum of 3 quarters · filed 2026-02-20 | $410.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $133.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $211.00M derived: sum of 2 quarters · filed 2026-02-20 | $310.00M derived: sum of 3 quarters · filed 2026-02-20 | $399.00M 10-K · filed 2026-02-20 |
| 2023-10-01 | $78.00M 10-Q · filed 2024-11-07 | $177.00M derived: sum of 2 quarters · filed 2024-11-07 | $266.00M 10-Q · filed 2024-11-07 | $369.00M derived: sum of 4 quarters · filed 2025-02-24 |
| 2023-07-02 | $99.00M 10-Q · filed 2024-08-06 | $188.00M 10-Q · filed 2024-08-06 | $291.00M derived: sum of 3 quarters · filed 2025-02-24 | $381.00M derived: sum of 4 quarters · filed 2025-02-24 |
| 2023-04-02 | $89.00M 10-Q · filed 2024-05-09 | $192.00M derived: sum of 2 quarters · filed 2025-02-24 | $282.00M derived: sum of 3 quarters · filed 2025-02-24 | $376.00M derived: sum of 4 quarters · filed 2025-02-24 |
| 2023-01-01 | $103.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $193.00M derived: sum of 2 quarters · filed 2025-02-24 | $287.00M derived: sum of 3 quarters · filed 2025-02-24 | $375.00M 10-K · filed 2025-02-24 |
| 2022-10-02 | $90.00M 10-Q · filed 2023-11-03 | $184.00M derived: sum of 2 quarters · filed 2023-11-03 | $272.00M 10-Q · filed 2023-11-03 | |
| 2022-07-03 | $94.00M 10-Q · filed 2023-08-02 | $182.00M 10-Q · filed 2023-08-02 | ||
| 2022-04-03 | $88.00M 10-Q · filed 2023-06-02 | |||
| 2022-01-02 | $355.00M 10-K · filed 2024-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| e.l.f. Beauty, Inc. (ELF) | United States | $5.934B | |
| INTERPARFUMS INC (IPAR) | United States | $3.707B | 21.36 |
| COTY INC. (COTY) | United States | $2.307B | -3.15 |
| EDGEWELL PERSONAL CARE Co (EPC) | United States | $1.261B | -13.27 |
| SOLESENCE, INC. (SLSN) | United States | $0.058B | -25.13 |
| Axil Brands, Inc. (AXIL) | United States | $0.042B | 17.24 |
| UNITED GUARDIAN INC (UG) | United States | $0.034B | 13.30 |
| Caring Brands, Inc. (CABR) | United States | $0.013B | |
| BONK, INC. (BNKK) | United States | $0.011B | -0.14 |
| cbdMD, Inc. (YCBD) | United States | $0.005B | -2.59 |